Bhagya Laxmi Dyavar Shetty

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation”.

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

Nature Communications(2022)10.1038/s41467-022-30902-7

N/A

1.4DataRank · unranked

46 citations

Brady Sillman, Aditya N. Bade, Sean N. Avedissian, Anthony T. Podany, JoEllyn McMillan +18 more

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles

Nature Communications(2021)10.1038/s41467-021-25690-5

N/A

1.3DataRank · unranked

53 citations

Nathan Smith, Suyash Deodhar, Aditya N. Bade, Nagsen Gautam, Bhagya Laxmi Dyavar Shetty +6 more

Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L‐Dopa‐induced dyskinesia in parkinsonian rats

Genes Brain & Behavior(2020)10.1111/gbb.12690

N/A

0DataRank · unranked

12 citations

Lisa F. Potts, Goichi Beck, Bhagya Laxmi Dyavar Shetty, Benton Lawson, Anthony T. Podany +4 more

Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir

Nature Communications(2021)10.1038/s41467-021-23668-x

N/A

0DataRank · unranked

45 citations

JoEllyn McMillan, Devendra Kumar, Aditya N. Bade, Qiaoyu Pan, Tanmay A. Kulkarni +9 more

Pathways for Dolutegravir Transformation from a Daily Oral to a Once-a-Year Parenteral Medicine

Research Square(2022)10.21203/rs.3.rs-1255147/v1

N/A

0DataRank · unranked

0 citations

Brady Sillman, Aditya N. Bade, JoEllyn McMillan, Nagsen Gautam, Brandon Hanson +15 more